Biotechnology in Asia Pacific
Biotechnology in Asia Pacific
SUMMARY
Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The Asia-Pacific biotechnology market had total revenues of $100.4bn in 2019, representing a compound annual growth rate (CAGR) of 5.3% between 2015 and 2019.
- The medical/healthcare segment was the market's most lucrative in 2019, with total revenues of $52.9bn, equivalent to 52.7% of the market's overall value.
- Compared with pharmas, biotech companies will have more difficulty compensating for supply chain disruptions from COVID-19, due to the high costs associated with their R&D.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Asia-Pacific
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Asia-Pacific
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific biotechnology market with five year forecasts
- What was the size of the Asia-Pacific biotechnology market by value in 2019?
- What will be the size of the Asia-Pacific biotechnology market in 2024?
- What factors are affecting the strength of competition in the Asia-Pacific biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Asia-Pacific's biotechnology market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. Have there been any new product launches in recent years?
7.4. What has been the rationale behind M&A activity in recent years?
7.5. What are the strengths of leading players?
7.6. How might COVID-19 affect the competitive landscape?
8 COMPANY PROFILES
8.1. Shanghai Kehua Bio-engineering Co Ltd
8.2. Astellas Pharma China Inc
8.3. Novo Nordisk Pharmatech A/S
8.4. Takeda Pharmaceutical Company Limited
9 APPENDIX
9.1. Methodology
9.2. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. Have there been any new product launches in recent years?
7.4. What has been the rationale behind M&A activity in recent years?
7.5. What are the strengths of leading players?
7.6. How might COVID-19 affect the competitive landscape?
8 COMPANY PROFILES
8.1. Shanghai Kehua Bio-engineering Co Ltd
8.2. Astellas Pharma China Inc
8.3. Novo Nordisk Pharmatech A/S
8.4. Takeda Pharmaceutical Company Limited
9 APPENDIX
9.1. Methodology
9.2. About MarketLine
LIST OF TABLES
Table 1: Asia-Pacific biotechnology industry value: $ billion, 2015-19
Table 2: Asia-Pacific biotechnology industry category segmentation: $ billion, 2019
Table 3: Asia-Pacific biotechnology industry geography segmentation: $ billion, 2019
Table 4: Asia-Pacific biotechnology industry value forecast: $ billion, 2019-24
Table 5: Shanghai Kehua Bio-engineering Co Ltd: key facts
Table 6: Shanghai Kehua Bio-engineering Co Ltd: Annual Financial Ratios
Table 7: Shanghai Kehua Bio-engineering Co Ltd: Key Employees
Table 8: Astellas Pharma China Inc: key facts
Table 9: Astellas Pharma China Inc: Key Employees
Table 10: Novo Nordisk Pharmatech A/S: key facts
Table 11: Novo Nordisk Pharmatech A/S: Key Employees
Table 12: Takeda Pharmaceutical Company Limited: key facts
Table 13: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 14: Takeda Pharmaceutical Company Limited: Annual Financial Ratios (Continued)
Table 15: Takeda Pharmaceutical Company Limited: Key Employees
Table 16: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 1: Asia-Pacific biotechnology industry value: $ billion, 2015-19
Table 2: Asia-Pacific biotechnology industry category segmentation: $ billion, 2019
Table 3: Asia-Pacific biotechnology industry geography segmentation: $ billion, 2019
Table 4: Asia-Pacific biotechnology industry value forecast: $ billion, 2019-24
Table 5: Shanghai Kehua Bio-engineering Co Ltd: key facts
Table 6: Shanghai Kehua Bio-engineering Co Ltd: Annual Financial Ratios
Table 7: Shanghai Kehua Bio-engineering Co Ltd: Key Employees
Table 8: Astellas Pharma China Inc: key facts
Table 9: Astellas Pharma China Inc: Key Employees
Table 10: Novo Nordisk Pharmatech A/S: key facts
Table 11: Novo Nordisk Pharmatech A/S: Key Employees
Table 12: Takeda Pharmaceutical Company Limited: key facts
Table 13: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 14: Takeda Pharmaceutical Company Limited: Annual Financial Ratios (Continued)
Table 15: Takeda Pharmaceutical Company Limited: Key Employees
Table 16: Takeda Pharmaceutical Company Limited: Key Employees Continued
LIST OF FIGURES
Figure 1: Asia-Pacific biotechnology industry value: $ billion, 2015-19
Figure 2: Asia-Pacific biotechnology industry category segmentation: % share, by value, 2019
Figure 3: Asia-Pacific biotechnology industry geography segmentation: % share, by value, 2019
Figure 4: Asia-Pacific biotechnology industry value forecast: $ billion, 2019-24
Figure 5: Forces driving competition in the biotechnology industry in Asia-Pacific, 2019
Figure 6: Drivers of buyer power in the biotechnology industry in Asia-Pacific, 2019
Figure 7: Drivers of supplier power in the biotechnology industry in Asia-Pacific, 2019
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Asia-Pacific, 2019
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Asia-Pacific, 2019
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Asia-Pacific, 2019
Figure 1: Asia-Pacific biotechnology industry value: $ billion, 2015-19
Figure 2: Asia-Pacific biotechnology industry category segmentation: % share, by value, 2019
Figure 3: Asia-Pacific biotechnology industry geography segmentation: % share, by value, 2019
Figure 4: Asia-Pacific biotechnology industry value forecast: $ billion, 2019-24
Figure 5: Forces driving competition in the biotechnology industry in Asia-Pacific, 2019
Figure 6: Drivers of buyer power in the biotechnology industry in Asia-Pacific, 2019
Figure 7: Drivers of supplier power in the biotechnology industry in Asia-Pacific, 2019
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Asia-Pacific, 2019
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Asia-Pacific, 2019
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Asia-Pacific, 2019
